Dizziness / vertigo
This medicine may cause dizziness or vertigo.
Leaflet OLMETEC 10mg film-coated tablets
- Product code:
- W67484001
- Quantity:
- 14
- Indicated for:
- hypertension
- Route of administration:
- oral
- Substance:
- olmesartan medoxomil (antihypertensive)
- ATC
- C09CA08 — Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain
Precautions:
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hypotension / fall risk
May lower blood pressure and increase the risk of falls.
Major drug interactions
This medicine may have important interactions with other medicines.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Electrolyte disturbances
This medicine may change blood electrolyte levels.
Olmesartan medoxomil is an angiotensin II receptor antagonist used for the treatment of hypertension. It works by blocking the effects of angiotensin II, a hormone that causes blood vessels to constrict, thereby lowering blood pressure.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.
Patients should be aware of potential side effects, such as dizziness, headaches, or nausea. It is important to inform the doctor of any unusual symptoms.
Common side effects include dizziness, headaches, nausea, and fatigue. In rare cases, severe reactions such as kidney failure or hyperkalemia may occur. Patients should be informed of these risks before starting treatment.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.
Patients should be aware of potential side effects, such as dizziness, headaches, or nausea. It is important to inform the doctor of any unusual symptoms.
Common side effects include dizziness, headaches, nausea, and fatigue. In rare cases, severe reactions such as kidney failure or hyperkalemia may occur. Patients should be informed of these risks before starting treatment.
General data about OLMETEC 10mg
- Substance:
- olmesartan medoxomil
- Date of latest medicines list:
- 01-04-2021
- Product code:
- W67484001
- Concentration:
- 10mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 14
- Product type:
- Original
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Concentrations available for olmesartan medoxomil
- 10mg
- 20mg
- 40mg